Boditech Med Inc. (206640.KQ)

KRW 17340.0

(0.29%)

Revenue Summary of Boditech Med Inc.

Boditech Med Inc.'s latest annual revenue in 2023 was 134.21 Billion KRW , up 13.67% from previous year.
Boditech Med Inc.'s latest quarterly revenue in 2024 Q2 was 36.24 Billion KRW , up 9.52% from previous quarter.
Boditech Med Inc. reported a annual revenue of 118.07 Billion KRW in annual revenue 2022, down -25.13% from previous year.
Boditech Med Inc. reported a annual revenue of 157.7 Billion KRW in annual revenue 2021, up 9.42% from previous year.
Boditech Med Inc. reported a quarterly revenue of 36.24 Billion KRW for 2024 Q2, up 9.52% from previous quarter.
Boditech Med Inc. reported a quarterly revenue of 34.95 Billion KRW for 2023 Q2, up 18.58% from previous quarter.

Annual Revenue Chart of Boditech Med Inc. (2023 - 2015)

Historical Annual Revenue of Boditech Med Inc. (2023 - 2015)

Year	Revenue	Revenue Growth
2023	134.21 Billion KRW	13.67%
2022	118.07 Billion KRW	-25.13%
2021	157.7 Billion KRW	9.42%
2020	144.13 Billion KRW	97.99%
2019	72.79 Billion KRW	9.96%
2018	66.2 Billion KRW	25.88%
2017	52.59 Billion KRW	-4.33%
2016	54.97 Billion KRW	38.05%
2015	39.82 Billion KRW	0.0%

Year	Revenue	Revenue Growth
2024 Q1	33.09 Billion KRW	-5.24%
2024 Q2	36.24 Billion KRW	9.52%
2023 Q2	34.95 Billion KRW	18.58%
2023 FY	134.21 Billion KRW	13.67%
2023 Q3	34.86 Billion KRW	-0.26%
2023 Q1	29.47 Billion KRW	2.13%
2023 Q4	34.92 Billion KRW	0.19%
2022 FY	118.07 Billion KRW	-25.13%
2022 Q1	37.33 Billion KRW	1.31%
2022 Q2	24.12 Billion KRW	-35.37%
2022 Q3	27.74 Billion KRW	15.0%
2022 Q4	28.86 Billion KRW	4.01%
2021 FY	157.7 Billion KRW	9.42%
2021 Q3	43.87 Billion KRW	4.72%
2021 Q1	35.09 Billion KRW	-38.18%
2021 Q2	41.89 Billion KRW	19.39%
2021 Q4	36.85 Billion KRW	-16.0%
2020 Q2	31.18 Billion KRW	99.95%
2020 FY	144.13 Billion KRW	97.99%
2020 Q4	56.75 Billion KRW	39.84%
2020 Q3	40.58 Billion KRW	30.15%
2020 Q1	15.59 Billion KRW	-18.31%
2019 Q4	19.09 Billion KRW	1.35%
2019 FY	72.79 Billion KRW	9.96%
2019 Q1	18.25 Billion KRW	0.32%
2019 Q2	16.61 Billion KRW	-9.0%
2019 Q3	18.83 Billion KRW	13.39%
2018 FY	66.2 Billion KRW	25.88%
2018 Q4	18.19 Billion KRW	-2.95%
2018 Q2	15.6 Billion KRW	14.35%
2018 Q3	18.74 Billion KRW	20.13%
2018 Q1	13.64 Billion KRW	-3.23%
2017 Q2	13.34 Billion KRW	0.04%
2017 Q1	13.33 Billion KRW	-6.18%
2017 FY	52.59 Billion KRW	-4.33%
2017 Q4	14.1 Billion KRW	19.42%
2017 Q3	11.81 Billion KRW	-11.47%
2016 Q2	15.71 Billion KRW	55.65%
2016 Q4	14.21 Billion KRW	-4.86%
2016 Q1	10.09 Billion KRW	-0.51%
2016 Q3	14.94 Billion KRW	-4.96%
2016 FY	54.97 Billion KRW	38.05%
2015 Q4	10.15 Billion KRW	-8.4%
2015 FY	39.82 Billion KRW	0.0%
2015 Q3	11.08 Billion KRW	4.74%
2015 Q1	8 Billion KRW	0.0%
2015 Q2	10.58 Billion KRW	32.16%

Peer Revenue Comparison of Boditech Med Inc.

Name	Revenue	Revenue Difference
HLB Pharmaceutical Co., Ltd	135.95 Billion KRW	1.275%
CMG Pharmaceutical Co., Ltd.	93.9 Billion KRW	-42.928%
Celltrion Pharm, Inc.	388.79 Billion KRW	65.478%
Huons Global Co., Ltd.	758.37 Billion KRW	82.302%
DongKook Pharmaceutical Co., Ltd.	730.99 Billion KRW	81.639%
Enzychem Lifesciences Corporation	76.03 Billion KRW	-76.514%
Humedix Co., Ltd.	152.27 Billion KRW	11.857%
EuBiologics Co., Ltd.	69.36 Billion KRW	-93.495%
FutureChem Co.,Ltd	13.96 Billion KRW	-860.904%
Huons Co., Ltd.	552 Billion KRW	75.685%
BNC Korea Co., Ltd.	80.99 Billion KRW	-65.708%
AptaBio Therapeutics Inc.	323.86 Million KRW	-41342.471%